BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33516531)

  • 1. Active surveillance as a management option for cervical intraepithelial neoplasia 2: An online experimental study.
    Dodd RH; Cvejic E; Bell K; Black K; Bateson D; Smith MA; Mac OA; McCaffery KJ
    Gynecol Oncol; 2021 Apr; 161(1):179-187. PubMed ID: 33516531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding women's choices for management of cervical intraepithelial neoplasia 2 (CIN2): Qualitative analysis of a randomised experimental study.
    Keers G; Yamada K; Pickles K; Bell K; Black K; Bateson D; Dodd RH
    Aust N Z J Obstet Gynaecol; 2022 Feb; 62(1):125-132. PubMed ID: 34625954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial.
    Cotton S; Sharp L; Little J; Cruickshank M; Seth R; Smart L; Duncan I; Harrild K; Neal K; Waugh N;
    BJOG; 2010 May; 117(6):645-59. PubMed ID: 20374607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus Test for Triage of Japanese Women With Low-Grade Squamous Intraepithelial Lesions.
    Iwata T; Hasegawa T; Ochiai K; Takizawa K; Umezawa S; Kuramoto H; Ohmura M; Kubushiro K; Arai H; Sakamoto M; Motoyama T; Watanabe K; Aoki D
    Reprod Sci; 2015 Dec; 22(12):1509-15. PubMed ID: 26092278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "I feel reassured, but there is no guarantee." How do women with a future childbearing desire respond to active surveillance of cervical intraepithelial neoplasia grade 2? A qualitative study.
    Hansen J; Kirkegaard P; Folmann B; Bungum HF; Hammer A
    Acta Obstet Gynecol Scand; 2022 Jun; 101(6):616-623. PubMed ID: 35383881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
    van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcome of high-grade cervical intraepithelial neoplasia during pregnancy: A 10-year experience.
    Hong DK; Kim SA; Lim KT; Lee KH; Kim TJ; So KA
    Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():173-176. PubMed ID: 30933887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
    Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
    JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the human papillomavirus status on the development of high-grade cervical intraepithelial neoplasia in women negative for intraepithelial lesions or malignancy at the baseline: A 9-year Swedish nested case-control follow-up study.
    Fröberg M; Östensson E; Belkić K; Oštrbenk A; Poljak M; Mints M; Arbyn M; Andersson S
    Cancer; 2019 Jan; 125(2):239-248. PubMed ID: 30536370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1.
    Boardman LA; Kennedy CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):599-614; ix. PubMed ID: 19061819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
    Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing triage algorithms using HPV DNA genotyping, HPV E7 mRNA detection and cytology in high-risk HPV DNA-positive women.
    Luttmer R; Berkhof J; Dijkstra MG; van Kemenade FJ; Snijders PJ; Heideman DA; Meijer CJ
    J Clin Virol; 2015 Jun; 67():59-66. PubMed ID: 25959161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
    Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
    Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
    Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Franco EL;
    Int J Cancer; 2021 Jan; 148(2):492-501. PubMed ID: 32781481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.